Esteban Burrone
@eburrone.bsky.social
Public health professional working on innovation and access to health products
Reposted by Esteban Burrone
🌍 Join our mission
📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa
📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.
📢 Board Member Opportunity
👉 medicinespatentpool.org/who-we-are/c...
📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa
📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.
📢 Board Member Opportunity
👉 medicinespatentpool.org/who-we-are/c...
August 21, 2025 at 9:25 AM
🌍 Join our mission
📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa
📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.
📢 Board Member Opportunity
👉 medicinespatentpool.org/who-we-are/c...
📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa
📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.
📢 Board Member Opportunity
👉 medicinespatentpool.org/who-we-are/c...
Reposted by Esteban Burrone
"Expanding our licence with ViiV Healthcare to include long-acting cabotegravir for #HIV treatment marks a significant step forward for equitable access”
- @medicinespatentpool.org's Esteban Burrone 🇨🇭 #IAS2025
- @medicinespatentpool.org's Esteban Burrone 🇨🇭 #IAS2025
July 14, 2025 at 1:53 PM
"Expanding our licence with ViiV Healthcare to include long-acting cabotegravir for #HIV treatment marks a significant step forward for equitable access”
- @medicinespatentpool.org's Esteban Burrone 🇨🇭 #IAS2025
- @medicinespatentpool.org's Esteban Burrone 🇨🇭 #IAS2025
Reposted by Esteban Burrone
The MPP and ViiV have expanded their agreement to now include cabotegravir long-acting for both #HIV prevention and treatment.
This is the first fully long-acting HIV treatment made available through a voluntary licence in low- and middle- income countries.
#IAS2025 #ViiV #Unitaid
This is the first fully long-acting HIV treatment made available through a voluntary licence in low- and middle- income countries.
#IAS2025 #ViiV #Unitaid
July 14, 2025 at 2:01 PM
Reposted by Esteban Burrone
Ahead of #WorldIPDay, we’re launching the #MedsPaL Tutorial Series, your guide to navigating MPP’s patents and licences database 🌍💊
🔍 Learn how to perform a basic search, explore #patent results, and access licence and #data exclusivity information!
👉 www.youtube.com/watch?v=JPlW...
www.medspal.org
🔍 Learn how to perform a basic search, explore #patent results, and access licence and #data exclusivity information!
👉 www.youtube.com/watch?v=JPlW...
www.medspal.org
🎥 #1 Tutorial - MedsPaL Tutorial Series
YouTube video by MedicinesPatentPool
www.youtube.com
April 25, 2025 at 1:55 PM
Ahead of #WorldIPDay, we’re launching the #MedsPaL Tutorial Series, your guide to navigating MPP’s patents and licences database 🌍💊
🔍 Learn how to perform a basic search, explore #patent results, and access licence and #data exclusivity information!
👉 www.youtube.com/watch?v=JPlW...
www.medspal.org
🔍 Learn how to perform a basic search, explore #patent results, and access licence and #data exclusivity information!
👉 www.youtube.com/watch?v=JPlW...
www.medspal.org
Reposted by Esteban Burrone
"Our teams in the Democratic Republic of Congo say that they have not received antiretroviral supplies at the MSF-run CHK Hospital in Kinshasa since 20 January, leaving over 2,000 HIV/TB patients at risk of developing drug resistance, advanced HIV and dying,if supplies are not resumed immediately."
March 19, 2025 at 4:28 PM
"Our teams in the Democratic Republic of Congo say that they have not received antiretroviral supplies at the MSF-run CHK Hospital in Kinshasa since 20 January, leaving over 2,000 HIV/TB patients at risk of developing drug resistance, advanced HIV and dying,if supplies are not resumed immediately."
Reposted by Esteban Burrone
📢 MPP & @lstmnews.bsky.social signed a MOU to enhance global access to LSTM’s IP portfolio. 🌍✨
🙌 This collaboration aims to incorporate access-oriented clauses in LSTM agreements, such as an affordable access plan provision in licences for early-stage medical tech.
🔗 bit.ly/40eQYDt
🙌 This collaboration aims to incorporate access-oriented clauses in LSTM agreements, such as an affordable access plan provision in licences for early-stage medical tech.
🔗 bit.ly/40eQYDt
Upstream Access Plan for Health Technologies in LMICs
Discover how MPP partners with funders to create affordable access plans for health technologies, ensuring life-saving products reach LMICs
bit.ly
March 18, 2025 at 3:20 PM
📢 MPP & @lstmnews.bsky.social signed a MOU to enhance global access to LSTM’s IP portfolio. 🌍✨
🙌 This collaboration aims to incorporate access-oriented clauses in LSTM agreements, such as an affordable access plan provision in licences for early-stage medical tech.
🔗 bit.ly/40eQYDt
🙌 This collaboration aims to incorporate access-oriented clauses in LSTM agreements, such as an affordable access plan provision in licences for early-stage medical tech.
🔗 bit.ly/40eQYDt
Reposted by Esteban Burrone
Some positive news for a change re: Global Health funding, as #Canada announces a pledge of $675 million over the next five years (2026-2030) for #Gavi, The Vaccine Alliance. www.canada.ca/en/global-af...
March 7, 2025 at 4:22 PM
Some positive news for a change re: Global Health funding, as #Canada announces a pledge of $675 million over the next five years (2026-2030) for #Gavi, The Vaccine Alliance. www.canada.ca/en/global-af...
February 27, 2025 at 5:43 PM
Reposted by Esteban Burrone
Celebrating #WorldAIDSDay2024 with insights from Nelson Otwoma, Director of NEPHAK. Discover Kenya's journey in #HIV treatment, the impact of access to dolutegravir through voluntary licensing & the support of many partners & ongoing efforts to improve the lives of those affected.
bit.ly/4eU9Ahp
bit.ly/4eU9Ahp
December 1, 2024 at 8:40 AM
Celebrating #WorldAIDSDay2024 with insights from Nelson Otwoma, Director of NEPHAK. Discover Kenya's journey in #HIV treatment, the impact of access to dolutegravir through voluntary licensing & the support of many partners & ongoing efforts to improve the lives of those affected.
bit.ly/4eU9Ahp
bit.ly/4eU9Ahp